Warby Parker

American eyeglasses and contact lens retailer

WRBY NYSE SEC CIK 1504776
Follow Warby Parker Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $244.7M +10.4% vs same quarter last year
Net income $5.6M −4.6% vs same quarter last year
EPS, diluted $0.04 −20% vs same quarter last year
Operating cash flow $24.7M +37.5% vs same quarter last year
Revenue by quarter
$190.6M
$223.8M
$214.5M
$221.7M
$212M
$242.4M
$235.5M
$244.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1BFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$871.9M$1.6M
FY24$771.3M−$20.4M
FY23$669.8M−$63.2M
FY22$598.1M−$110.4M
FY21$540.8M−$144.3M
FY20$393.7M−$55.9M
FY19$370.5M$0
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%−25%0%25%50%75%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2554%−0.6%0.2%
FY2455.3%−3.9%−2.6%
FY2354.5%−10.7%−9.4%
FY2257%−18.6%−18.5%
FY2158.8%−26.6%−26.7%
FY2058.9%−14.1%−14.2%
FY1960.2%−0.4%0%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$43.7M
FY24$34.7M
FY23$7.3M
FY22−$49.8M
FY21−$80.5M
FY20$12.7M
FY19−$11.2M
FY18-
Returned to shareholdersDividends paid and shares bought back
$0$20M$40M$60M$80MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearBuybacks
FY25-
FY24-
FY23$0
FY22$0
FY21$8.1M
FY20$0
FY19$79.5M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Warby Parker
  • Healthcare median
−100%−75%−50%−25%0%25%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearWarby ParkerHealthcare median
FY250.2%−30.6%
FY24−2.6%−47%
FY23−9.4%−58%
FY22−18.5%−80.4%
FY21−26.7%−71.9%
FY20−14.2%−62.2%
FY190%−46.3%
FY18-−49.6%